$0.95
cbdMD
Performance
Dividends
1W
1M
YTD
1Y
3Y
11/36
Growth
Score
16/36
Dividend
Score
Valuation
PE Ratio
-6.38
PS Ratio
0.43
RSI
-
PEG Ratio
0
PRG Ratio
-0.15
0
PDG Ratio
0
Growth
2023
2024
2025*
2026*
3
Revenue
Revenue
*Analyst estimated growth
Fundamentals
Rule
of 40
66.57%
Gross Margin
62.35%
0
Current Ratio
0
Return on Assets
0%
0
Return on Equity
-0.69%
3
Return on inv. Capital
87.95%
Institutional Holder
Shares
Holders
Financials
Yealy
Quarterly
Revenue 2024 19.48M
2018
2019
2020
2021
2022
2023
2024
6
Net Income 2024 -3.70M
2018
2019
2020
2021
2022
2023
2024
6
Gross Profit 2024 12.00M
2018
2019
2020
2021
2022
2023
2024
6
Events
YCBD
cbdMD
in 271 days
after market close
Earnings per Share is expected with - and revenue with - .
YCBD
cbdMD
in 180 days
after market close
Earnings per Share is expected with - and revenue with - .
YCBD
cbdMD
in 123 days
after market close
Earnings per Share is expected with - and revenue with - .
About
Sector/Industry
Healthcare
Drug Manufacturers - Specialty & Generic
IPO Date
17.11.2017
MaketCap
8.46M
Country
US
CEO
T. Ronan Kennedy
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
Updated 28.07.2025